Strain, W. D., & Paldánius, P. M. (2017). Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes. Eur Endocrinol.
استشهاد بنمط شيكاغوStrain, William David, و Päivi M. Paldánius. "Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes." Eur Endocrinol 2017.
MLA استشهادStrain, William David, و Päivi M. Paldánius. "Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes." Eur Endocrinol 2017.